# Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet

> **NCT00747929** · PHASE2 · COMPLETED · sponsor: **Shionogi** · enrollment: 724 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** S-2367 Placebo
- **DRUG:** S-2367 800 mg
- **DRUG:** S-2367 1600 mg
- **OTHER:** Reduced Calorie Diet

## Key facts

- **NCT ID:** NCT00747929
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-11
- **Final completion:** 2009-01
- **Target enrollment:** 724 (ACTUAL)
- **Last updated:** 2018-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00747929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00747929, "Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00747929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*